Skip to main content
Erschienen in: The International Journal of Cardiovascular Imaging 3/2011

01.03.2011 | Original Paper

Peak systolic longitudinal strain of the lateral left ventricular wall improves after septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: a follow-up study using speckle tracking echocardiography

verfasst von: Lothar Faber, Christian Prinz, Dirk Welge, Detlef Hering, Thomas Butz, Olaf Oldenburg, Nicola Bogunovic, Dieter Horstkotte

Erschienen in: The International Journal of Cardiovascular Imaging | Ausgabe 3/2011

Einloggen, um Zugang zu erhalten

Abstract

Speckle tracking echocardiography (STE) or two-dimensional (2D) strain imaging is a novel ultrasound method to assess myocardial deformation. Peak systolic longitudinal strain (PSLS) of the basal septum (IVS) and the opposite lateral (LVFW) wall were measured in addition to standard echocardiography in 88 consecutive patients (pts) with obstructive hypertrophic cardiomyopathy (HOCM) who underwent a septal ablation procedure (PTSMA) and who were re-evaluated 12 ± 12 after months. At baseline, PSLS was substantially reduced both in basal regions. While PSLS remained unchanged in the basal IVS, i.e. the target region for PTSMA (baseline: −5.3 ± 4.1%; follow-up: −6.0 ± 4.3%; P = 0.06), it improved in the opposite LVFW (from −9.4 ± 4.7 to −12.4 ± 4.8%; P < 0.0001). Wall thickness decreased in both regions (Septum: from 20 ± 4 to 17 ± 4 mm; P < 0.0001; LV free wall: from 13 ± 2 to 12 ± 2 mm; P = 0.001). PSLS correlated significantly with wall thickness, both at baseline and at follow-up. NYHA functional class (from 2.9 ± 0.4 to 1.6 ± 0.6; P < 0.0001) and objective exercise capacity (from 96 ± 42 to 114 ± 42 W; P = 0.001) improved together with the reduction of outflow obstruction (LVOTO: from 62 ± 30 to 11 ± 19 mm Hg at rest, from 121 ± 26 to 43 ± 40 mm Hg with provocation; P < 0.0001). During the 12 months of observation, no patient had a severe adverse event. Regional myocardial deformation can be assessed quantitatively by STE. Reduction of LV afterload by elimination of the outflow gradient following a successful PTSMA with low doses of alcohol results in improvement of systolic lateral longitudinal function.
Literatur
1.
Zurück zum Zitat Wigle DE, Rakowski H, Kimball BP, Williams WG (1995) Hypertrophic cardiomyopathy: clinical spectrum and treatment. Circulation 92:1680–1692PubMed Wigle DE, Rakowski H, Kimball BP, Williams WG (1995) Hypertrophic cardiomyopathy: clinical spectrum and treatment. Circulation 92:1680–1692PubMed
2.
Zurück zum Zitat Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, Shah PM, Spencer WH III, Spirito P, Ten Cate FJ, Wigle ED, Vogel RA, Abrams J, Bates ER, Brodie BR, Danias PG, Gregoratos G, Hlatky MA, Hochman JS, Kaul S, Lichtenberg RC, Lindner JR, O’Rourke RA, Pohost GM, Schofield RS, Tracy CM, Winters WL Jr, Klein WW, Priori SG, Alonso-Garcia A, Blomstrom-Lundqvist C, De Backer G, Deckers J, Flather M, Hradec J, Oto A, Parkhomenko A, Silber S, Torbicki A (2003) American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 42:1687–1713PubMedCrossRef Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, Shah PM, Spencer WH III, Spirito P, Ten Cate FJ, Wigle ED, Vogel RA, Abrams J, Bates ER, Brodie BR, Danias PG, Gregoratos G, Hlatky MA, Hochman JS, Kaul S, Lichtenberg RC, Lindner JR, O’Rourke RA, Pohost GM, Schofield RS, Tracy CM, Winters WL Jr, Klein WW, Priori SG, Alonso-Garcia A, Blomstrom-Lundqvist C, De Backer G, Deckers J, Flather M, Hradec J, Oto A, Parkhomenko A, Silber S, Torbicki A (2003) American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 42:1687–1713PubMedCrossRef
3.
Zurück zum Zitat Maron MS, Olivotto I, Zenovich AG, Link MS, Pandian NG, Kuvin JT, Cecchi F, Udelson JE, Maon BJ (2006) Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation 114:2232–2239PubMedCrossRef Maron MS, Olivotto I, Zenovich AG, Link MS, Pandian NG, Kuvin JT, Cecchi F, Udelson JE, Maon BJ (2006) Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation 114:2232–2239PubMedCrossRef
4.
Zurück zum Zitat Sigwart U (1995) Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet 346:211–214PubMedCrossRef Sigwart U (1995) Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet 346:211–214PubMedCrossRef
5.
Zurück zum Zitat Kimmelstiel CD, Maron BJ (2004) Role of percutaneous septal ablation in hypertrophic obstructive cardiomyopathy. Circulation 109:452–456PubMedCrossRef Kimmelstiel CD, Maron BJ (2004) Role of percutaneous septal ablation in hypertrophic obstructive cardiomyopathy. Circulation 109:452–456PubMedCrossRef
6.
Zurück zum Zitat Knight CJ, Kurbaan AS, Seggewiss H, Henein M, Gunning M, Harrington D, Fassbender D, Gleichmann U, Sigwart U (1997) Non-surgical septal reduction for hypertrophic obstructive cardiomyopathy: outcome in the first series of patients. Circulation 95:2075–2081PubMed Knight CJ, Kurbaan AS, Seggewiss H, Henein M, Gunning M, Harrington D, Fassbender D, Gleichmann U, Sigwart U (1997) Non-surgical septal reduction for hypertrophic obstructive cardiomyopathy: outcome in the first series of patients. Circulation 95:2075–2081PubMed
7.
Zurück zum Zitat Kuhn H, Gietzen F, Leuner C, Gerenkamp T (1997) Induction of subaortic septal ischemia to reduce obstruction in hypertrophic obstructive cardiomyopathy. Eur Heart J 18:846–851PubMed Kuhn H, Gietzen F, Leuner C, Gerenkamp T (1997) Induction of subaortic septal ischemia to reduce obstruction in hypertrophic obstructive cardiomyopathy. Eur Heart J 18:846–851PubMed
8.
Zurück zum Zitat Braunwald E (1997) Induced septal infarction: a new strategy for hypertrophic obstructive cardiomyopathy. Circulation 95:1981PubMed Braunwald E (1997) Induced septal infarction: a new strategy for hypertrophic obstructive cardiomyopathy. Circulation 95:1981PubMed
9.
Zurück zum Zitat Faber L, Seggewiss H, Gleichmann U (1998) Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: results with respect to intra-procedural myocardial contrast echocardiography. Circulation 98:2415–2421PubMed Faber L, Seggewiss H, Gleichmann U (1998) Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: results with respect to intra-procedural myocardial contrast echocardiography. Circulation 98:2415–2421PubMed
10.
Zurück zum Zitat Flores-Ramirez R, Lakkis NM, Middleton KJ, Killip D, Spencer WH 3rd, Nagueh SF (2001) Echocardiographic insights into the mechanisms of relief of left ventricular outflow tract obstruction after nonsurgical septal reduction therapy in patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 37:208–214PubMedCrossRef Flores-Ramirez R, Lakkis NM, Middleton KJ, Killip D, Spencer WH 3rd, Nagueh SF (2001) Echocardiographic insights into the mechanisms of relief of left ventricular outflow tract obstruction after nonsurgical septal reduction therapy in patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 37:208–214PubMedCrossRef
11.
Zurück zum Zitat Lakkis NM, Nagueh SF, Kleiman NS, Killip DM, He ZX, Verani M, Roberts R, Spencer WH III (1998) Echocardiography-guided ethanol septal reduction for hypertrophic obstructive cardiomyopathy. Circulation 98:1750–1755PubMed Lakkis NM, Nagueh SF, Kleiman NS, Killip DM, He ZX, Verani M, Roberts R, Spencer WH III (1998) Echocardiography-guided ethanol septal reduction for hypertrophic obstructive cardiomyopathy. Circulation 98:1750–1755PubMed
12.
Zurück zum Zitat Seggewiss H, Gleichmann U, Faber L, Fassbender D, Schmidt HK, Strick S (1998) Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-months follow-up in 25 patients. J Am Coll Cardiol 31:252–258PubMedCrossRef Seggewiss H, Gleichmann U, Faber L, Fassbender D, Schmidt HK, Strick S (1998) Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-months follow-up in 25 patients. J Am Coll Cardiol 31:252–258PubMedCrossRef
13.
Zurück zum Zitat Faber L, Seggewiss H, Ziemssen P (2000) Targeting percutaneous transluminal septal ablation for HOCM by intra-procedural echocardiographic monitoring. J Am Soc Echocardiogr 13:1074–1079PubMedCrossRef Faber L, Seggewiss H, Ziemssen P (2000) Targeting percutaneous transluminal septal ablation for HOCM by intra-procedural echocardiographic monitoring. J Am Soc Echocardiogr 13:1074–1079PubMedCrossRef
14.
Zurück zum Zitat Faber L, Meissner A, Ziemssen P, Seggewiss H (2000) Percutaneous transluminal septal myocardial ablation for HOCM: long-term follow-up in the first series of 25 patients. Heart 83:326–331PubMedCrossRef Faber L, Meissner A, Ziemssen P, Seggewiss H (2000) Percutaneous transluminal septal myocardial ablation for HOCM: long-term follow-up in the first series of 25 patients. Heart 83:326–331PubMedCrossRef
15.
Zurück zum Zitat Heric B, Lytle BW, Miller OP (1995) Surgical management of hypertrophic obstructive cardiomyopathy. J Thor Cardiovasc Surg 110:195–208CrossRef Heric B, Lytle BW, Miller OP (1995) Surgical management of hypertrophic obstructive cardiomyopathy. J Thor Cardiovasc Surg 110:195–208CrossRef
16.
Zurück zum Zitat Schulte HD, Bircks W, Lösse B (1987) Techniques and complications of transaortic subvalvular myectomy in patients with hypertrophic obstructive cardiomyopathy (HOCM). Z Kardiol 76(suppl 3):145–151PubMed Schulte HD, Bircks W, Lösse B (1987) Techniques and complications of transaortic subvalvular myectomy in patients with hypertrophic obstructive cardiomyopathy (HOCM). Z Kardiol 76(suppl 3):145–151PubMed
17.
Zurück zum Zitat Robbins RC, Stinson EB, Daily PO (1996) Long-term results of left ventricular myotomy and myectomy for obstructive hypertrophic cardiomyopathy. J Thorac Cardiovasc Surg 111:586–594PubMedCrossRef Robbins RC, Stinson EB, Daily PO (1996) Long-term results of left ventricular myotomy and myectomy for obstructive hypertrophic cardiomyopathy. J Thorac Cardiovasc Surg 111:586–594PubMedCrossRef
18.
Zurück zum Zitat Ralph-Edwards A, Woo A, McCrindle BW, Shapero JL, Schwartz L, Rakowski H, Wigle DE, Williams WG (2005) Hypertrophic obstructive cardiomyopathy: comparison of outcomes after myectomy or alcohol ablation adjusted by propensity score. J Thorac Cardiovasc Surg 129:351–358PubMedCrossRef Ralph-Edwards A, Woo A, McCrindle BW, Shapero JL, Schwartz L, Rakowski H, Wigle DE, Williams WG (2005) Hypertrophic obstructive cardiomyopathy: comparison of outcomes after myectomy or alcohol ablation adjusted by propensity score. J Thorac Cardiovasc Surg 129:351–358PubMedCrossRef
19.
Zurück zum Zitat Minami K, Boethig D, Woltersdorf H, Seifert D, Koerfer R (2002) Long-term follow-up of surgical treatment of HOCM. Eur J Cardiothorac Surg 22:206–210PubMedCrossRef Minami K, Boethig D, Woltersdorf H, Seifert D, Koerfer R (2002) Long-term follow-up of surgical treatment of HOCM. Eur J Cardiothorac Surg 22:206–210PubMedCrossRef
20.
Zurück zum Zitat Nagueh SF, Ommen SR, Lakkis NM, Killip D, Zoghbi WA, Schaff HV, Danielson GK, Quinones MA, Tajik JA, Spencer WH (2001) Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 38:1707–1710CrossRef Nagueh SF, Ommen SR, Lakkis NM, Killip D, Zoghbi WA, Schaff HV, Danielson GK, Quinones MA, Tajik JA, Spencer WH (2001) Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 38:1707–1710CrossRef
21.
Zurück zum Zitat Qin JX, Shiota T, Lever HM, Kapadia SR, Sitges M, Rubin DN, Bauer F, Greenberg NL, Agler DA, Drinko JK, Martin M, Tuzcu EM, Smedira NG, Lytle B, Thomas JD (2001) Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery. J Am Coll Cardiol 38:1994–2000PubMedCrossRef Qin JX, Shiota T, Lever HM, Kapadia SR, Sitges M, Rubin DN, Bauer F, Greenberg NL, Agler DA, Drinko JK, Martin M, Tuzcu EM, Smedira NG, Lytle B, Thomas JD (2001) Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery. J Am Coll Cardiol 38:1994–2000PubMedCrossRef
22.
Zurück zum Zitat Qin JX, Shiota T, Lever HM, Asher CR, Popovic ZB, Greenberg NL, Agler DA, Drinko JK, Smedira NG, Tuzcu EM, Lytle BW, Thomas JD (2004) Conduction system abnormalities in patients with obstructive hypertrophic cardiomyopathy following septal reduction interventions. Am J Cardiol 93:171–175PubMedCrossRef Qin JX, Shiota T, Lever HM, Asher CR, Popovic ZB, Greenberg NL, Agler DA, Drinko JK, Smedira NG, Tuzcu EM, Lytle BW, Thomas JD (2004) Conduction system abnormalities in patients with obstructive hypertrophic cardiomyopathy following septal reduction interventions. Am J Cardiol 93:171–175PubMedCrossRef
23.
Zurück zum Zitat Veselka J, Duchonova R, Prochazkova S, Palenickova J, Sorajja P, Tesar D (2005) Effects of varying dosing in percutaneous septal ablation for obstructive HCM on early hemodynamic changes. Am J Cardiol 95:675–678PubMedCrossRef Veselka J, Duchonova R, Prochazkova S, Palenickova J, Sorajja P, Tesar D (2005) Effects of varying dosing in percutaneous septal ablation for obstructive HCM on early hemodynamic changes. Am J Cardiol 95:675–678PubMedCrossRef
24.
Zurück zum Zitat Faber L, Seggewiss H, Gietzen FH, Kuhn H, Boekstegers P, Neuhaus L, Seipel L, Horstkotte D (2005) Catheter-based septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: follow-up results of the “TASH”-registry of the German Cardiac Society. Z Kardiol 94:516–523PubMedCrossRef Faber L, Seggewiss H, Gietzen FH, Kuhn H, Boekstegers P, Neuhaus L, Seipel L, Horstkotte D (2005) Catheter-based septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: follow-up results of the “TASH”-registry of the German Cardiac Society. Z Kardiol 94:516–523PubMedCrossRef
25.
Zurück zum Zitat Cheitlin MD, For the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography) (2003) ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography. J Am Soc Echocardiogr 16:1091–1110PubMed Cheitlin MD, For the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography) (2003) ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography. J Am Soc Echocardiogr 16:1091–1110PubMed
26.
Zurück zum Zitat Yang H, Sun JP, Lever HM et al (2003) Use of strain imaging in detecting segmental dysfunction in patients with hypertrophic cardiomyopathy. J Am Soc Echocardiogr 16:233–239PubMedCrossRef Yang H, Sun JP, Lever HM et al (2003) Use of strain imaging in detecting segmental dysfunction in patients with hypertrophic cardiomyopathy. J Am Soc Echocardiogr 16:233–239PubMedCrossRef
27.
Zurück zum Zitat Kato TS, Noda A, Izawa H et al (2004) Discrimination of nonobstructive hypertrophic cardiomyopathy from hypertensive left ventricular hypertrophy on the basis of strain rate imaging by tissue Doppler ultrasonography. Circulation 110:3808–3814PubMedCrossRef Kato TS, Noda A, Izawa H et al (2004) Discrimination of nonobstructive hypertrophic cardiomyopathy from hypertensive left ventricular hypertrophy on the basis of strain rate imaging by tissue Doppler ultrasonography. Circulation 110:3808–3814PubMedCrossRef
28.
Zurück zum Zitat Amundsen BH, Helle-Valle T, Edvardsen T, Torp H, Crosby J, Lyseggen E, Stoylen A, Ihlen H, Lima JA, Smiseth OA, Slordahl SA (2006) Noninvasive myocardial strain measurement by speckle tracking echocardiography: validation against sonomicrometry and tagged magnetic resonance imaging. J Am Coll Cardiol 47:789–793PubMedCrossRef Amundsen BH, Helle-Valle T, Edvardsen T, Torp H, Crosby J, Lyseggen E, Stoylen A, Ihlen H, Lima JA, Smiseth OA, Slordahl SA (2006) Noninvasive myocardial strain measurement by speckle tracking echocardiography: validation against sonomicrometry and tagged magnetic resonance imaging. J Am Coll Cardiol 47:789–793PubMedCrossRef
29.
Zurück zum Zitat Leitman M, Lysyansky P, Sidenko S et al (2004) Two-dimensional strain—a novel software for real-time quantitative echocardiographic assessment of myocardial function. J Am Soc Echocardiogr 17:1021–1029PubMedCrossRef Leitman M, Lysyansky P, Sidenko S et al (2004) Two-dimensional strain—a novel software for real-time quantitative echocardiographic assessment of myocardial function. J Am Soc Echocardiogr 17:1021–1029PubMedCrossRef
30.
Zurück zum Zitat Serri K, Reant P, Lafitte M, Berhouet M, Le Bouffos V, Roudaut R, Lafitte S (2006) Global and regional myocardial function quantification by two-dimensional strain: application in hypertrophic cardiomyopathy. J Am Coll Cardiol 47:1175–1181PubMedCrossRef Serri K, Reant P, Lafitte M, Berhouet M, Le Bouffos V, Roudaut R, Lafitte S (2006) Global and regional myocardial function quantification by two-dimensional strain: application in hypertrophic cardiomyopathy. J Am Coll Cardiol 47:1175–1181PubMedCrossRef
31.
Zurück zum Zitat Cho GY, Chan J, Leano R, Strudwick M, Marwick TH (2006) Comparison of two-dimensional speckle and tissue velocity based strain and validation with harmonic phase magnetic resonance imaging. Am J Cardiol 97:1661–1666PubMedCrossRef Cho GY, Chan J, Leano R, Strudwick M, Marwick TH (2006) Comparison of two-dimensional speckle and tissue velocity based strain and validation with harmonic phase magnetic resonance imaging. Am J Cardiol 97:1661–1666PubMedCrossRef
32.
Zurück zum Zitat Helle-Valle T, Crosby J, Edvardsen T, Lyseggen E, Amundsen BH, Smith HJ, Rosen BD, Lima JA, Torp H, Ihlen H, Smiseth OA (2005) New noninvasive method for assessment of left ventricular rotation: speckle tracking echocardiography. Circulation 112:3149–3156PubMedCrossRef Helle-Valle T, Crosby J, Edvardsen T, Lyseggen E, Amundsen BH, Smith HJ, Rosen BD, Lima JA, Torp H, Ihlen H, Smiseth OA (2005) New noninvasive method for assessment of left ventricular rotation: speckle tracking echocardiography. Circulation 112:3149–3156PubMedCrossRef
33.
Zurück zum Zitat Notomi Y, Lysyansky P, Setser RM, Shiota T, Popovic ZB, Martin-Miklovic MG, Weaver JA, Oryszak SJ, Greenberg NL, White RD, Thomas JD (2005) Related measurement of ventricular torsion by two-dimensional ultrasound speckle tracking imaging. J Am Coll Cardiol 45:2034–2041PubMedCrossRef Notomi Y, Lysyansky P, Setser RM, Shiota T, Popovic ZB, Martin-Miklovic MG, Weaver JA, Oryszak SJ, Greenberg NL, White RD, Thomas JD (2005) Related measurement of ventricular torsion by two-dimensional ultrasound speckle tracking imaging. J Am Coll Cardiol 45:2034–2041PubMedCrossRef
34.
Zurück zum Zitat Van Dockum WG, Beek AM, Ten Cate FJ, Ten Berg JM, Bondarenko O, Gotte MJ, Twisk JW, Hofman MB, Visser CA, van Rossum AC (2005) Early onset and progression of left ventricular remodeling after alcohol septal ablation in hypertrophic obstructive cardiomyopathy. Circulation 111:2503–2508PubMedCrossRef Van Dockum WG, Beek AM, Ten Cate FJ, Ten Berg JM, Bondarenko O, Gotte MJ, Twisk JW, Hofman MB, Visser CA, van Rossum AC (2005) Early onset and progression of left ventricular remodeling after alcohol septal ablation in hypertrophic obstructive cardiomyopathy. Circulation 111:2503–2508PubMedCrossRef
35.
Zurück zum Zitat Van Dockum WG, Kuijer JPA, Goette MJW, Ten Cate FJ, Ten Berg JM, Beek AM, Twisk JWR, Marcus JT, Visser CA, van Rossum AC (2006) Septal ablation in hypertrophic cardiomyopathy improves systolic myocardial function in the lateral (free) wall: a follow-up study using CMR tissue tagging and 3D strain analysis. Eur Heart J 27:2833–2839PubMedCrossRef Van Dockum WG, Kuijer JPA, Goette MJW, Ten Cate FJ, Ten Berg JM, Beek AM, Twisk JWR, Marcus JT, Visser CA, van Rossum AC (2006) Septal ablation in hypertrophic cardiomyopathy improves systolic myocardial function in the lateral (free) wall: a follow-up study using CMR tissue tagging and 3D strain analysis. Eur Heart J 27:2833–2839PubMedCrossRef
36.
Zurück zum Zitat Deb SJ, Schaff HV, Dearani JA, Nishimura RA, Ommen SR (2004) Septal myectomy results in regression of LV hypertrophy in patients with HOCM. Ann Thorac Surg 78:2118–2122PubMedCrossRef Deb SJ, Schaff HV, Dearani JA, Nishimura RA, Ommen SR (2004) Septal myectomy results in regression of LV hypertrophy in patients with HOCM. Ann Thorac Surg 78:2118–2122PubMedCrossRef
37.
Zurück zum Zitat D’Andrea A, D’Andrea L, Caso P, Scherillo M, Zeppillio P, Calabro R (2006) The usefulness of Doppler myocardial imaging in the study of the athlete’s heart and in the differential diagnosis between physiological and pathological ventricular hypertrophy. Echocardiography 23:149–157PubMedCrossRef D’Andrea A, D’Andrea L, Caso P, Scherillo M, Zeppillio P, Calabro R (2006) The usefulness of Doppler myocardial imaging in the study of the athlete’s heart and in the differential diagnosis between physiological and pathological ventricular hypertrophy. Echocardiography 23:149–157PubMedCrossRef
38.
Zurück zum Zitat Otto CM (2006) Valvular aortic stenosis: disease severity and timing of intervention. J Am Coll Cardiol 47:2141–2151PubMedCrossRef Otto CM (2006) Valvular aortic stenosis: disease severity and timing of intervention. J Am Coll Cardiol 47:2141–2151PubMedCrossRef
Metadaten
Titel
Peak systolic longitudinal strain of the lateral left ventricular wall improves after septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: a follow-up study using speckle tracking echocardiography
verfasst von
Lothar Faber
Christian Prinz
Dirk Welge
Detlef Hering
Thomas Butz
Olaf Oldenburg
Nicola Bogunovic
Dieter Horstkotte
Publikationsdatum
01.03.2011
Verlag
Springer Netherlands
Erschienen in
The International Journal of Cardiovascular Imaging / Ausgabe 3/2011
Print ISSN: 1569-5794
Elektronische ISSN: 1875-8312
DOI
https://doi.org/10.1007/s10554-010-9678-0

Weitere Artikel der Ausgabe 3/2011

The International Journal of Cardiovascular Imaging 3/2011 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.